NASDAQ: DNLI Denali Therapeutics Inc. 8-K

Denali regains full rights to DNL593 as Takeda terminates collaboration agreement

Filed April 3, 2026 · Period ending April 3, 2026 · ~1 min read

3 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade DNLI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 7:42 PM